BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/21/2021 6:41:08 AM | Browse: 370 | Download: 486
 |
Received |
|
2021-02-26 14:07 |
|
Peer-Review Started |
|
2021-02-26 14:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-27 05:09 |
|
Revised |
|
2021-04-29 09:42 |
|
Second Decision |
|
2021-06-04 07:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-06-04 10:07 |
|
Articles in Press |
|
2021-06-04 10:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-15 23:44 |
|
Publish the Manuscript Online |
|
2021-06-21 06:41 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ester Oneda, Chiara Abeni, Laura Zanotti, Elisabetta Zaina, Sara Bighè and Alberto Zaniboni |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ester Oneda, MD, Doctor, Department of Clinical Oncology, Fondazione Poliambulanza, Via Bissolati 57, Brescia 25124, Italy. dott.ester.oneda@gmail.com |
| Key Words |
Peripheral neuropathy; Ovarian cancer; Paclitaxel; Chemotherapy-induced peripheral neuropathy prevention; Hilotherapy |
| Core Tip |
The association of carboplatin and paclitaxel is the standard chemotherapy regimen for ovarian cancer women. One of the most common and disabling side effect of this treatment is the peripheral neuropathy caused by paclitaxel, it can occur in 20% of patients and can last months and even years after the end of chemotherapy. In this review we collected the evidence from several studies with different schedules or formulation of paclitaxel and the systems of prevention and propose a mechanical way of prevention adopted in our center through the use of the cooling system of the hilotherm device. |
| Publish Date |
2021-06-21 06:41 |
| Citation |
Oneda E, Abeni C, Zanotti L, Zaina E, Bighè S, Zaniboni A. Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention. World J Clin Oncol 2021; 12(6): 458-467 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i6/458.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i6.458 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
